A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With Advanced Cancer (Solid Tumours)

NCT07744152 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
137
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim